Ozempic Maker Novo Nordisk Sues Eli Lilly Over 'Materially Misleading' Ads
The fierce commercial rivalry between the two dominant players in the weight-loss drug market has spilled into the courtroom, with Ozempic maker Novo Nordisk accusing its biggest US competitor of misleading advertising